Article

EP. 4: EyeCon 2022: Mindset to explore new opportunities for your practice

Key Takeaways

  • EyeCon 2022 will feature leading ophthalmologists sharing new data and strategies for patient care.
  • The conference is scheduled for December 16-17 at the JW Marriott Marco Island Beach Resort, Florida.
SHOW MORE

An interactive agenda at the Ophthalmology Times® EyeCon 2022 at the JW Marriott Marco Island Beach Resort in Florida will foster an open exchange of ideas with fellow attendees from across the United States.

This December, Ophthalmology Times® EyeCon 2022 will gather the nation’s leading ophthalmologists to share new data and practical strategies that clinicians can apply to their patients. The conference will take place December 16 to 17 at the JW Marriott Marco Island Beach Resort in Florida.

Co-chairs Peter J. McDonnell, MD, director of the Wilmer Eye Institute at Johns Hopkins University School of Medicine in Baltimore, Maryland, and Oluwatosin U. Smith, MD, of Glaucoma Associates of Texas in Dallas recently spoke with Ophthalmology Times®’ Group Editorial Director Sheryl Stevenson for the top reasons to attend this year's EyeCon 2022. Here is the fourth in a series of five segments.

To learn more about or to register for Ophthalmology Times® EyeCon 2022, click here.

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
(Image credit: Ophthalmology Times) CCOI's new CEO Malvina Eydelman, MD, outlines her mission and vision for the organization
CIME 2025: Neda Shamie, MD, on expanding options in pharmacological presbyopia management
(Image credit: Ophthalmology Times) ASCRS 2025: Deb Ristvedt, DO, on medications, lasers, and lifestyle in glaucoma management
(Image credit: Ophthalmology Times) ASCRS 2025: Mark Lobanoff, MD, on making the move to office-based surgery
Barsha Lal, PhD, discusses the way low dose atropine affects accommodative amplitude and dynamics at the 2025 ARVO meeting
(Image credit: Ophthalmology Times) NeuroOp Guru: When eye findings should prompt neuroimaging in suspected neuro-Behcet disease
At the Association for Research in Vision and Ophthalmology (ARVO) meeting, Katherine Talcott, MD, a retina specialist at Cleveland Clinic, shared her findings on EYP-1901 (EyePoint Pharmaceuticals) in the phase 2 DAVIO study.
Dr. Jogin Desai, founder of Eyestem Research, discusses his research at the Association for Research in Vision and Ophthalmology.
© 2025 MJH Life Sciences

All rights reserved.